The article you are looking for is not available.
Perhaps you would be interested in our most recent articles.
In vitro anti-tubercular activity of the two novel 1,2,4-triazole derivatives demonstrated dose-dependent inhibition of Mycobacterium tuberculosis.
read more
Bulk solids handling is common in pharmaceutical manufacturing, but it remains one of the most misunderstood and underestimated engineering challenges.
read more
GFF treatment led to a significant improvement in FEV1% and FEV1/FVC ratios and resulted in faster, more consistent improvements than TFF.
read more
When regulations contradict the natural laws of science, they may impose a substantial hardship on manufacturers.
read more
Current practice is to apply uniform hold times across the manufacturing process, but this causes operational constraints and insufficient microbial control.
read more
Pharmaceutical manufacturers who use automation and AI models improve processes, scale more quickly, and gain the agility to meet shifting market demands.
read more
The technical challenges of polymersomes necessitate complex custom synthesis, advanced analytical characterization, and clear pathways to scale up.
read more
In commercial manufacturing, the level of effort and assessment need to be proportional to the identified risk.
read more
Although clinical trial ethics are straightforward on paper, ethics has always been about drawing lines precisely where the science gets most tempting.
read more
Within the pharmaceutical industry, alternative and rapid microbiological methods (AMM/RMMs) have been implemented for a wide range of applications including sterile and nonsterile finished product ...
read more